Charts

In the latest trading session, Ardelyx (ARDX) closed at $4.05, marking a +0.5% move from the previous day.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation. The post 7 Core Stocks to Build a Solid Portfolio Around appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Top healthcare stocks include Theravance Biopharma for best value, Signify Health for fastest growth, and TransMedics Group for most momentum.

According to Benzinga Pro, during Q4, Ardelyx (NASDAQ:ARDX) earned $10.70 million, a 146.72% increase from the preceding quarter. ...

Ardelyx, Inc. ( NASDAQ:ARDX ) shareholders will have a reason to smile today, with the analysts making substantial...

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday. The Dow traded up ...

After the market close Thursday,Ardelyx Inc(NASDAQ: ARDX) reported Q4 FY22 Ibsrelasales of $8.7 millionand ...

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic ...

Gainers Seer (NASDAQ:SEER) shares moved upwards by 39.4% to $5.87 during Friday's regular session. As of 12:30 EST, Seer's stock is ...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up ...

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ardelyx swung from an earnings loss to a profit and an analyst took notice of the company's progress. Now, ARDX stock is catching a bid. The post Why Is Ardelyx (ARDX) Stock Up 25% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Upgrades JP Morgan upgraded the previous rating for Casey's General Stores Inc (NASDAQ:CASY) from Underweight to Neutral. In the second ...

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap ...

Q4 2022 Ardelyx Inc Earnings Call

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 31.5% to $3.59 during Thursday's after-market session. The company's ...

Continued successful launch of IBSRELA, ending FY 2022 with $15.6 million in net product sales Resubmission of XPHOZAH New Drug Application expected in early Q2 2023 Company ends Q4 with approximately $123.9 million in cash and investments Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines t

Report focuses on patient access and affordability, workforce wellness and training, community involvement and sound corporate governanceWALTHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today published its 2022 Environmental, Social and Governance (ESG) Report, the first time the company has report

InvestorPlace - Stock Market News, Stock Advice & Trading Tips So, what are the best stocks for cautious investors today? Take a look at these seven. Each one earns an A rating in Portfolio Grader. The post 7 Smart Stock Picks for Cautious Investors appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a GI/Microbiome panel discussion at the Cowen 43rd Annual Health Care Conference on Monday March 6, 2023 at 9:10 A.M. Eastern Time in Boston, MA. To

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco NASDAQ Future Gen 200 ETF (QQQS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $45.06 per unit.

Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, March 2, 2023, at 4:30 p.m. Eastern Time to discuss fourth quarter and full year 2022 financial results and provide a business update. To

Here is how Ardelyx (ARDX) and Agile Therapeutics (AGRX) have performed compared to their sector so far this year.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. The post 7 A-Rated Penny Stocks Worth Betting On appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

InvestorPlace - Stock Market News, Stock Advice & Trading Tips A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns. The post 7 Stocks Under $10 to Buy in February appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Ardelyx (ARDX) closed at $3.02 in the latest trading session, marking a -1.63% move from the prior day.

Ardelyx (ARDX) is expected to report better-than-expected sales growth of its only marketed product, Ibsrela (tenapanor) and provide an update on the NDA resubmission timeline for Xphozah, tenapanor.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. The post 7 A-Rated Healthcare Stocks to Buy for the Future of Medicine appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

InvestorPlace - Stock Market News, Stock Advice & Trading Tips So, what are some of the best high-quality stocks to buy today this month? Consider these seven. Each one currently earns an A rating in Portfolio Grader. The post 7 A-Rated Stocks to Buy for February 2023 appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Ardelyx, Inc. ( NASDAQ:ARDX ) is possibly approaching a major achievement in its business, so we would like to shine...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips So, what are the best stocks to buy for less than $25 per share? Consider these seven. Each one earns an A rating in Portfolio Grader. The post 7 A-Rated Stocks to Buy for Less Than $25 appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco NASDAQ Future Gen 200 ETF (QQQS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $46.78 per unit.

U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Friday. Here are some big stocks recording gains in ...

Investors in Ardelyx Inc (ARDX) saw new options become available this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARDX options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

Ardelyx Inc (NASDAQ: ARDX) shares are trading lower by 17.03% to $2.67 Thursday morning after the company filed for a mixed shelf ...

Gainers Apexigen (NASDAQ:APGN) shares moved upwards by 39.7% to $2.5 during Thursday's pre-market session. The company's market cap ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Having gambled in under-the-radar penny stocks myself, I can tell you firsthand, the outcome hasn’t always been great. There are a lot of risks involved, so tread lightly. Many experts will advise you to steer clear of penny stocks – and for good reason. Oftentimes, they’ll tempt speculative traders with the idea of easy growth,.... The post 5 Under-the-Radar Penny Stocks With 100% Upside Potential appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bondsand ...

Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7.Citigroup analyst Yigal Nochomovitz maintained a ...

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Following the market opening ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors should be able to profit from some of the biggest opportunities for penny stock investors identified in this column. The post The 3 Biggest Opportunities for Penny Stock Investors in 2023 appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom ...

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading ...

Ardelyx Inc(NASDAQ: ARDX) shares are down after an update regarding the appeal to theComplete Response ...

Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t stop people from seeking treatments for a myriad of issues. Plus, there’s growing demand for innovation in gene therapies, immune-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical.... The post The 7 Hottest Biotech Stocks to Own in 2023 and Beyond appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Ardelyx's (NASDAQ:ARDX) short percent of float has risen 16.96% since its last report. The company recently reported that it has ...

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth. The post 3 Biotech Stocks Smart Investors Should Be Buying Up Now appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses ...

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. FOXO Technologies Inc. (NYSE: FOXO) ...

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains ...

Recent analyst upgrades suggest these stocks can triple your money or better.

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to ...

Piper Sandlerraised its price target onArdelyx Inc(NASDAQ: ARDX) to $8 from $3 and upgraded toOverweight from ...

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. Elevate Credit, Inc. (NYSE: ELVT) ...

U.S. stocks closed slightly lower on Thursday, with the S&P 500 dropping around 0.3%. Here is the list of some big stocks recording ...